LIFE Atyr Pharma Inc
aTyr Pharma Inc is a biotherapeutics company, engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using its Physiocrine biology.
$2.24 -0.03 (-1.32%)
As of 02/02/2023 16:00:00 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Micro cap
GICS sector: Health Care
Industry: Biotechnology
Index country: USA
Country of incorporation: USA
IPO date: 05/07/2015
Outstanding shares: 28,625,046
Average volume: 139,738
Market cap: $64,978,854
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Quarterly filings:
10-Q
Annual filings:
10-K
Sedol:
Valuation (See tab for details)
PE ratio: -3.38
PB ratio: 0.64
PS ratio: 0.00
Return on equity: -39.34%
Net income %: -1,384,272.07%